elliptinium has been researched along with ellipticine in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (66.67) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Archer, S; el-Hamouly, W; Modi, SP; Portuese, E; Ruckdeschel, JC | 1 |
| Auclair, C; Hyland, K; Paoletti, C | 1 |
| Denny, WA; Feigon, J; Kearns, DR; Leupin, W | 1 |
| Auclair, C; Paoletti, C | 1 |
| Auclair, C; Dubreuil, P; Le Bret, M; Letard, S; Martin, F; Svinarchuk, F; Vendôme, J | 1 |
| Chen, GL; Liu, LF; Nelson, EM; Tewey, KM | 1 |
6 other study(ies) available for elliptinium and ellipticine
| Article | Year |
|---|---|
N-methylcarbamate derivatives of ellipticine and olivacine with cytotoxic activity against four human lung cancer cell lines.
Topics: Animals; Antineoplastic Agents, Phytogenic; Carbamates; Ellipticines; Humans; Leukemia L1210; Lung Neoplasms; Mice; Structure-Activity Relationship; Tumor Cells, Cultured | 1992 |
Autoxidation of the antitumor drug 9-hydroxyellipticine and its derivatives.
Topics: Alkaloids; Chemical Phenomena; Chemistry; Edetic Acid; Ellipticines; Kinetics; Manganese; Oxidation-Reduction; Oxygen Consumption; Spectrophotometry; Structure-Activity Relationship; Superoxide Dismutase | 1983 |
Interactions of antitumor drugs with natural DNA: 1H NMR study of binding mode and kinetics.
Topics: Antineoplastic Agents; Base Composition; Chemical Phenomena; Chemistry; DNA; Hydrogen Bonding; Intercalating Agents; Kinetics; Magnetic Resonance Spectroscopy; Structure-Activity Relationship | 1984 |
Bioactivation of the antitumor drugs 9-hydroxyellipticine and derivatives by a peroxidase-hydrogen peroxide system.
Topics: Alkaloids; Animals; Antineoplastic Agents; Biotransformation; Ellipticines; Hydrogen Peroxide; Mice; Oxidation-Reduction; Peroxidases; Structure-Activity Relationship | 1981 |
Molecular modeling of wild-type and D816V c-Kit inhibition based on ATP-competitive binding of ellipticine derivatives to tyrosine kinases.
Topics: Adenosine Triphosphate; Binding, Competitive; Ellipticines; Mutation; Protein Conformation; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-kit | 2005 |
Intercalative antitumor drugs interfere with the breakage-reunion reaction of mammalian DNA topoisomerase II.
Topics: Alkaloids; Animals; Antineoplastic Agents; Cattle; DNA; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; DNA, Viral; Ellipticines; HeLa Cells; Humans; Intercalating Agents; Kinetics; Osmolar Concentration; Plasmids; Protein Binding; Thymus Gland | 1984 |